10 related articles
How Ordinary People Can Invest in Spac…
How ordinary investors can access SpaceX, OpenAI and other top private companies through interval fund ARKVX and closed-end fund RV1 — no accredited investor status required.

Deep analysis of structural reasons behind Japan's software industry lag, examining how lifetime employment, multi-layer outsourcing amplify disadvantages in the AI era, and paths forward.

OpenAI launches GPT-Rosalind, its first frontier AI model for biology, drug discovery, and translational medicine. A deep dive into its capabilities, trusted access deployment, and industry impact.

A social science researcher shares hands-on experience with Google's latest AI research tools, analyzing Google's leadership in AI-accelerated science and future multi-disciplinary expansion.

Explore how the NVIDIA RTX PRO 4500 Blackwell workstation GPU accelerates genomic analysis and protein folding prediction, and its critical role in precision medicine and drug discovery.

Anthropic applies AI to biodefense — from early epidemic warnings and rapid vaccine R&D to threat assessment — exploring AI's critical role in global public health security.
Industry InsightsA simple tweet sparks wide discussion: What do you most want AI to solve? From healthcare to education equity and scientific research, exploring the shift from technology-driven to demand-driven AI.
Tech FrontiersGoogle introduces Gemini AI assistant in hiring to assess AI proficiency, OpenAI launches GPT-5.5 Cyber for critical infrastructure defense, Anthropic nears trillion-dollar valuation, Mozilla fixes 271 Firefox bugs with AI in two months.
Tech FrontiersWeekly AI roundup: Kimi K2.6 tops open-source rankings, Anthropic launches Opus 4.7 and Claude Design, Alibaba rolls out Qwen 3.6 series, Google releases emotion-controllable TTS model.
Tech FrontiersOn AlphaGo's 10th anniversary, Hassabis reunites with Lee Sedol in Korea. A look at how the 2016 match transformed Go theory, training, and AI's path to general intelligence.